2022 Annual Rare Cancers and Blood Disorders Program

Series CoursesThe Rare Cancers and Blood Disorders Program, in collaboration with the National Organization for Rare Disorders, is designed to be a resource for clinicians to facilitate the timely diagnosis and treatment of rare disease patients. The program highlights diagnostic approaches as a conduit for better treatment and outcomes, as well as equity and access in care, novel agents (recently approved and emerging), awareness of clinical trials, and advocacy resources to support patients and their families.